과제정보
The authors have received the following grant funding to support research on active surveillance or surgery for management of small, low risk papillary thyroid cancer: Ontario Academic Health Sciences Centres Alternate Funding Plan Innovation Grant (Ontario Ministry of Health), the Canadian Cancer Society (Lotte and John Hecht Memorial Foundation Innovation Grant, #703948 and the Innovation to Impact Grant, #706302), as well as the Canadian Institutes of Health Research (Project Grant, #PJT-162314). Anna M Sawka is supported, in part, by a Scientific Merit award from the University of Toronto Department of Medicine.
참고문헌
- Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol 2017;14:587-595
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133
- Kim CA, Yoo J, Oh HS, Jeon MJ, Chung SR, Baek JH, et al. Undercover active surveillance of small highly suspicious thyroid nodules without fine needle aspiration. Endocrine 2024;84:615-624
- Miyauchi A, Ito Y. Conservative surveillance management of low-risk papillary thyroid microcarcinoma. Endocrinol Metab Clin North Am 2019;48:215-226
- Sawka AM, Ghai S, Tomlinson G, Rotstein L, Gilbert R, Gullane P, et al. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer. BMJ Open 2018;8:e020298
- Ho AS, Kim S, Zalt C, Melany ML, Chen IE, Vasquez J, et al. Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial. JAMA Oncol 2022;8:1588-1596
- Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Chung KW, et al. Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis. Thyroid 2019;29:1399-1408
- Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma. Thyroid 2021;31:183-192
- Ghai S, O'Brien C, Goldstein DP, Sawka AM; Canadian Thyroid Cancer Active Surveillance Study Group. Ultrasound in active surveillance for low-risk papillary thyroid cancer: imaging considerations in case selection and disease surveillance. Insights Imaging 2021;12:130
- Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 2010;34:28-35
- Moon JH, Kim JH, Lee EK, Lee KE, Kong SH, Kim YK, et al. Study protocol of multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro). Endocrinol Metab (Seoul) 2018;33:278-286
- Molinaro E, Campopiano MC, Pieruzzi L, Matrone A, Agate L, Bottici V, et al. Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center. J Clin Endocrinol Metab 2020;105:e172-e180
- Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg 2017;143:1015-1020
- Sawka AM, Ghai S, Tomlinson G, Baxter NN, Corsten M, Imran SA, et al. A Protocol for a Pan-Canadian prospective observational study on active surveillance or surgery for very low risk papillary thyroid cancer. Front Endocrinol (Lausanne) 2021;12:686996
- Machens A, Holzhausen HJ, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 2005;103:2269-2273
- Bachar G, Buda I, Cohen M, Hadar T, Hilly O, Schwartz N, et al. Size discrepancy between sonographic and pathological evaluation of solitary papillary thyroid carcinoma. Eur J Radiol 2013;82:1899-1903
- Roman BR, Gupta P, Tuttle RM, Morris LGT, Lohia S. Assessing the number of candidates there are for active surveillance of low-risk papillary thyroid cancers in the US. JAMA Otolaryngol Head Neck Surg 2020;146:585-586
- Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006;30:780-786
- Chung SR, Baek JH, Choi YJ, Sung TY, Song DE, Kim TY, et al. Sonographic assessment of the extent of extrathyroidal extension in thyroid cancer. Korean J Radiol 2020;21:1187-1195
- Solymosi T, Hegedu˝s L, Bonnema SJ, Frasoldati A, Jambor L, Karanyi Z, et al. Considerable interobserver variation calls for unambiguous definitions of thyroid nodule ultrasound characteristics. Eur Thyroid J 2023;12:e220134
- Ito Y, Miyauchi A. Active surveillance of low-risk papillary thyroid microcarcinomas. Gland Surg 2020;9:1663-1673
- Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid 2018;28:23-31
- Ito Y, Miyauchi A, Oda H, Kobayashi K, Kihara M, Miya A. Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? World J Surg 2016;40:523-528
- Sanguedolce F, Tedde A, Granados L, Hernandez J, Robalino J, Suquilanda E, et al. Defining the role of multiparametric MRI in predicting prostate cancer extracapsular extension. World J Urol 2024;42:37
- Kumbhar SS, O'Malley RB, Robinson TJ, Maximin S, Lalwani N, Byrd DR, et al. Why thyroid surgeons are frustrated with radiologists: lessons learned from pre- and postoperative US. Radiographics 2016;36:2141-2153
- Ha EJ, Chung SR, Na DG, Ahn HS, Chung J, Lee JY, et al. 2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol 2021;22:2094-2123
- Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, Rago T, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2013;2:147-159
- Chung SR, Baek JH, Rho YH, Choi YJ, Sung TY, Song DE, et al. Sonographic diagnosis of cervical lymph node metastasis in patients with thyroid cancer and comparison of European and Korean guidelines for stratifying the risk of malignant lymph node. Korean J Radiol 2022;23:1102-1111
- Miyauchi A, Ito Y, Fujishima M, Miya A, Onoda N, Kihara M, et al. Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience. Thyroid 2023;33:817-825
- Nagaoka R, Ebina A, Toda K, Jikuzono T, Saitou M, Sen M, et al. Multifocality and progression of papillary thyroid microcarcinoma during active surveillance. World J Surg 2021;45:2769-2776
- Davies L, Chang CH, Sirovich B, Tuttle RM, Fukushima M, Ito Y, et al. Thyroid cancer active surveillance program retention and adherence in Japan. JAMA Otolaryngol Head Neck Surg 2021;147:77-84
- Kwon H, Oh HS, Kim M, Park S, Jeon MJ, Kim WG, et al. Active surveillance for patients with papillary thyroid microcarcinoma: a single center's experience in Korea. J Clin Endocrinol Metab 2017;102:1917-1925
- Oh HS, Kwon H, Song E, Jeon MJ, Kim TY, Lee JH, et al. Tumor volume doubling time in active surveillance of papillary thyroid carcinoma. Thyroid 2019;29:642-649
- Yamamoto M, Miyauchi A, Ito Y, Fujishima M, Sasaki T, Kudo T. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance. Surgery 2024;175:1089-1094
- Lee HJ, Yoon DY, Seo YL, Kim JH, Baek S, Lim KJ, et al. Intraobserver and interobserver variability in ultrasound measurements of thyroid nodules. J Ultrasound Med 2018;37:173-178
- Brauer VF, Eder P, Miehle K, Wiesner TD, Hasenclever H, Paschke R. Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid 2005;15:1169-1175
- Ito Y, Miyauchi A, Kudo T, Higashiyama T, Masuoka H, Kihara M, et al. Kinetic analysis of growth activity in enlarging papillary thyroid microcarcinomas. Thyroid 2019;29:1765-1773
- Chung SR, Choi YJ, Lee SS, Kim SO, Lee SA, Jeon MJ, et al. Interobserver reproducibility in sonographic measurement of diameter and volume of papillary thyroid microcarcinoma. Thyroid 2021;31:452-458
- Tuttle RM, Fagin J, Minkowitz G, Wong R, Roman B, Patel S, et al. Active surveillance of papillary thyroid cancer: frequency and time course of the six most common tumor volume kinetic patterns. Thyroid 2022;32:1337-1345
- Fukuoka O, Sugitani I, Ebina A, Toda K, Kawabata K, Yamada K. Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance. World J Surg 2016;40:529-537
- Lee JY, Kim JH, Kim YK, Lee CY, Lee EK, Moon JH, et al. US predictors of papillary thyroid microcarcinoma progression at active surveillance. Radiology 2023;309:e230006